AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.

AM Biotech’s groundbreaking “Cross-generational Bio-Pulse Exosome Application Platform”, which was awarded the National Innovation Award, can significantly reduce product development time and cost. Leveraging this platform, the company successfully launched Exo Giov in 2021, a cosmetic product harnessing the power of bio-pulsed exosomes for beauty and hair care. Additionally, AM Biotech is in the advanced stages of developing exosome-based treatments for a wide range of diseases, including menopause, ophthalmic disorders, otology, periodontitis, joint diseases, and chronic kidney disease.

Bio-Pulse Activation Technology

AM Biotech’s patented bio-pulse activation technology empowers the company to develop and produce high-quality bio-pulsed exosomes. Compared to conventional exosomes, AM Biotech’s exosomes exhibit significantly enhanced efficacy, with a 202% increase in protein content and a 188% increase in miRNA content. These enhancements make them highly effective in promoting cell repair and tissue regeneration.

Cross-generational Bio-Pulse Exosome Application Platform

This innovative platform is built upon AM Biotech’s patented bio-pulse activation technology and three other core technologies:

Bio-Pulse Activation Technology: Exosomes produced using this technology exhibit several to dozens of times greater efficacy in treating diseases, enhancing beauty, and promoting hair growth compared to conventional exosomes.
High-efficiency exosome production technology: Enables storage at room temperature.
Exosome Ultra-Purification Extraction Technology: Achieves a purity level of 99.99%.
Advanced Mass Production Process: Ensures consistent product quality.

AM Bio Tech’s “Patented Bio-Pulsed Technology Forum” held on December 15, 2024, successfully concluded. The event delved deep into the groundbreaking innovation behind Patented Bio-Pulsed Technology, shedding light on its mechanisms and providing compelling evidence of its effectiveness in skin rejuvenation and hair restoration.

The forum attracted a distinguished audience of medical aesthetics, beauty, and hair care professionals who were eager to learn more about this cutting-edge technology and its potential applications. Attendees gained valuable insights into the technology’s clinical efficacy, making it a compelling choice for their product offerings.

Dr. Huang Chi-Chia, President of the Chinese Society of Cosmetic Surgery and Anti-aging Medicine, emphasized the growing significance of Patented Bio-Pulsed Technology in the medical aesthetics industry. “This technology is not only innovative in its scientific underpinnings but also delivers tangible results in clinical practice,” he remarked. “It offers a comprehensive solution for both beauty and hair restoration.”

Scientific Validation and Clinical Success

Dr. Richard Hsieh, Chairman of AM Bio Tech highlighted AM Bio Tech’s unique patented bio-pulsed technology, which produces exosome medical raw materials with a purity of up to 99.99%. This exceptional purity translates into significantly enhanced collagen, elastin, and fibroblast production, as well as hair follicle stimulation compared to conventional exosomes. Moreover, AM Bio Tech’s technology allows for room temperature storage, expanding the applications of exosome-based hair care and skincare products.

Independent testing conducted by SGS further solidified the technology’s efficacy. The results revealed that 100% of participants experienced increased collagen levels and more even skin tone, while 97% reported increased hair density and stronger hair roots. These remarkable outcomes are attributed to AM Bio Tech’s Patented Bio-Pulsed Technology, which enables exosomes to interact with the skin and scalp more effectively.

Real-world Applications

Dr. Wang Si-ching of Nice Clinic shared her team’s clinical experience in utilizing Patented Bio-Pulsed Technology to treat skin aging and presented impressive before-and-after photos. Similarly, Dr. Tsai Zong-hua of Ferrari Clinic, a renowned expert in hair growth, showcased the clinical application of exosomes in hair regeneration, offering hope to individuals suffering from hair loss.

Regulatory Clarity

To ensure the safe and legal use of exosome products, the Taiwan Food and Drug Administration (TFDA) has established specific regulations for exosome cosmetics. During the forum, Yang Zi-yun from the TFDA’s Medical Devices and Cosmetic Division provided a detailed explanation of these regulations, including sales requirements for exosome products and the mandatory individual review process for human exosome raw materials.

Leading the Way in Exosome Innovation

As a pioneer in Induced bio-pulsed exosomes, AM Bio Tech is committed to further advancing research in this field. Beyond medical aesthetics, the company aims to develop innovative exosome-based products for various medical applications, including gynecology, dentistry, ophthalmology, nephrology, orthopedics, otolaryngology, and wound healing. AM Bio Tech is dedicated to bringing these products to the global market, improving the lives of people worldwide.

With outstanding R&D achievements and impressive revenue performance, Ascension Medical Biotechnology (AM BioTech) has formed a partnership with the Medical and Pharmaceutical Industry Technology and Development Center (PITDC) to launch multiple biotech projects and enter the trillion-dollar pharmaceutical market 3

Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30, 2024, its partnership with Medical and Pharmaceutical Industry Technology and Development Center (PITDC) through a “Pharmaceutical Project Cooperation Development Agreement.” This collaboration marks the official launch of several biotech and pharmaceutical development projects, as AM BioTech ventures into the trillion-dollar pharmaceutical market.

Leveraging its exclusive international patent for bio-pulsed technology, AM BioTech has applied this innovation to various medical and cosmetic research areas. The first commercial product utilizing this technology is ExoGiov, the world’s first exosome designed specifically for skin rejuvenation and hair growth. Unlike non-induced exosomes (Naive Exosomes), ExoGiov has achieved international recognition with an INCI certification in 2022. Its remarkable effectiveness, unique market position, and ease of use have led to significant revenue growth. The product, available in lyophilization powder, liquid, and skincare formulations, can be stored at room temperature, reflecting the company’s impressive performance within just three years of its establishment.

Dr. Richard Hsieh, Chairman of AM BioTech, stated that in addition to its applications in beauty and hair growth, the bio-pulsed technology is also being explored for potential pharmaceutical uses in obstetrics and gynecology, dentistry, ophthalmology, nephrology, orthopedics, otolaryngology, and major wound repair. Preclinical efficacy tests have been completed, and most animal trials are finalized, showing promising potential to address unmet medical needs in these fields. The company is actively positioning its international patents and will soon publish four international research papers.

Ensuring legal compliance and product development in both beauty and pharmaceutical sectors remains a core principle for AM BioTech. The company will adhere to international pharmaceutical regulations as it embarks on developing medical projects. The PITDC, renowned for its expertise in pharmaceutical development and regulatory affairs, will collaborate closely with AM BioTech. After extensive discussions and planning between both teams, the agreement will officially commence in September 2024. This partnership signifies a new milestone for AM BioTech as it enters the biotech pharmaceutical development arena.

Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30, 2024, its partnership with Medical and Pharmaceutical Industry Technology and Development Center (PITDC) through a “Pharmaceutical Project Cooperation Development Agreement.” This collaboration marks the official launch of several biotech and pharmaceutical development projects, as AM BioTech ventures into the trillion-dollar pharmaceutical market.

Dr. Mu-Huan Su, Chairman of the PITDC, emphasized that the center’s mission is to assist domestic companies with pharmaceutical product development and guidance while facilitating communication among industry, government, academia, and research sectors. This approach aims to enhance the technical standards of the pharmaceutical industry, promote technological advancement, and achieve industry upgrading and internationalization. The PITDC and AM BioTech have been discussing this project for three years, focusing on pharmaceutical initiatives. Given Taiwan’s relatively small market, it can be challenging for local industries to invest in such R&D. However, AM BioTech’s commitment to substantial research in new indications and applications is highly commendable. This collaboration will not only upgrade but also internationalize Taiwan’s industry. We aim to accelerate AM Biotech’s key pharmaceutical ingredients, product development and launch by partnering with the PITDC research team. Our collaboration will address both domestic and international regulations, enhance quality management systems, and implement manufacturing technologies. This will reduce the risks of AM Biotech’s self-funded development, shorten time to market, and speed up integration into the international supply chain. The planned development will proceed in two stages, aiming to maximize the benefits of domestically produced high-value pharmaceutical products.

Dr. Richard Hsieh, Chairman of AM BioTech, concluded by expressing confidence that, with the combined efforts of both teams, preliminary results will soon be visible, and the commercialization of pharmaceutical products will follow. AM BioTech’s research achievements and patent strategy are well-planned, offering a competitive market advantage. With the PITDC’s support and the collaborative development plan, the launch of AM BioTech’s products in various pharmaceutical applications is anticipated to be imminent.

Read Moreread more

Join Us at 2026 New York Society of Cosmetic Chemists

2026-05-08

Join Us at Cosmopack Asia 2025

2025-10-23

AM Biotech is honored to participate in Cosmopack Asia 2025, where we will present our

Join Us at the 2025 Autumn International Beauty & Cosmetics Show

2025-09-15

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With

Asia Healthcare & Medical Cosmetology Expo 2024

Exhibition Dates: July 25 to July 28, 2024
Exhibition Hours: 10:00 AM – 6:00 PM daily (until 5:00 PM on the last day)
Exhibition Venue: Nangang Exhibition Center, Hall 1, 1st Floor, Zone K (No. 1, Jingmao 2nd Road, Nangang District, Taipei City)
Booth Numbers: K622, K624

Biotechnology ✕ Beauty and Health “Asia Healthcare & Medical Cosmetology Expo 2024” showcases projects covering biotech pharmaceuticals, medicine, beauty care, and health. This year, AM Biotech is also participating, presenting our exclusive “Bio-Pulsed” patented technology, scientifically backed beauty and hair care ingredient ExoGiov® Bio-Pulsed Exosomes, and eagerly anticipated new products.

AM Biotech’s Core Technologies

• Exclusive Bio-Pulsed Patent Technology
• Cutting-Edge Manufacturing Process for Mass Production
• Ultra-Purification Extraction Technology for Exosomes
• High-Efficiency Exosome Production Technology for Room Temperature Storage

Advantages of ExoGiov® Bio-Pulsed Exosome Ingredients

• Smooth Wrinkles, Tighten Skin: Promotes the growth of skin-related fibroblasts, anti-inflammation, collagen, and elastin production, with effects 10 to 16 times higher than ordinary exosomes.
• Brighten Skin, Even Out Skin Tone: Degrades melanin miRNA, hundreds of times more effective than ordinary exosomes.
• Strengthen Hair Roots, Revitalize Scalp: Promotes and activates follicle cell growth, with effects 5 to 6 times higher than ordinary exosomes.

Read Moreread more

Join Us at 2026 New York Society of Cosmetic Chemists

2026-05-08

Join Us at Cosmopack Asia 2025

2025-10-23

AM Biotech is honored to participate in Cosmopack Asia 2025, where we will present our

Join Us at the 2025 Autumn International Beauty & Cosmetics Show

2025-09-15

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With

Reference: Npj Regenerative Medicine 〈Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis〉

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.

The kidneys play a critical role in filtering metabolic waste, regulating blood pressure, and maintaining the balance of fluids, electrolytes, and pH in our bodies. However, the onset of chronic illnesses such as diabetes, hypertension, and gout, or the improper use of medication, can lead to CKD. The progression of CKD is slow, often leaving the kidneys in a compromised state for extended periods, which can lead to renal fibrosis—a condition where the kidneys become scarred—and gradually result in a decline in kidney function. Eventually, this may advance to end-stage renal disease (ESRD), at which point most patients require dialysis or a kidney transplant.

A promising avenue for treating CKD, particularly in reducing renal fibrosis, involves the use of engineered extracellular vesicles. These vesicles encapsulate a protein known as CHIP (Carboxyl terminus of Hsp70 Interacting Protein), which plays a crucial role in protein management within cells.

In groundbreaking research highlighted in npj Regenerative Medicine, scientists conducted a study where CHIP-encapsulated extracellular vesicles were administered intravenously to rats that had undergone unilateral ureteral obstruction surgery to induce CKD. This surgery blocks one of the tubes that carries urine from the kidney to the bladder, simulating kidney conditions in humans.

After 14 days of treatment, the rats showed a significant reduction in kidney fibrosis. This result points to a potential non-invasive treatment option that could substantially alter the management of CKD and its progression to more severe stages. This innovative approach not only offers new hope for patients with chronic kidney conditions but also exemplifies the power of advanced biotechnological interventions in regenerative medicine.

Post-UUO Surgery Impact on Renal Fibrosis Treated with Exosomes

For more articlesread more

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

2024-05-24

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves

2024-04-24

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing

2024-03-27

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

Stem Cell Exosomes with Specific miRNAs: A New Frontier in Treating Male Pattern Baldness

2024-03-13

As the exploration of exosomes in clinical settings progresses, there's growing anticipation for their integration with existing treatments like Minoxidil and Finasteride. This innovative approach could herald a more comprehensive and effective solution for tackling male pattern baldness, promising a new era of hair loss

Exosomes Aid in Repairing Skin Aging Caused by UV Radiation

2024-02-02

Overexposure to UV rays stimulates the production of free radicals, leading to wrinkles, spots, and dullness. Therefore, it is essential to use sunscreen and engage in proper skincare to prevent and repair the signs of skin aging.

Anti-Aging Study: Exosomes Regulate Aging Skeletal Muscle

2024-01-05

Extracellular vesicles, including exosomes and microvesicles, are an important medium for intercellular communication, with nearly all cells secreting these vesicles. The research team compared aging muscle stem cells cultured with young serum to those with young serum depleted of extracellular vesicles, observing the impact of

Can Exosomes Also Treat Dry Eye Syndrome?!

2023-12-19

Biologically and medically speaking, immune cells activated after transplantation continuously attack hematopoietic tissues and ocular epithelial tissues, including the cornea, conjunctiva, and lacrimal glands, causing widespread inflammation.

“Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer of patented technology Bio-Pulsed Exosomes (Extracellular Vesicles), it is a Global Cross-Generation Innovative Cosmetic Ingredient recognized and favored by the international market in Europe and America.

AM BIOTECH is the exhibitor at In-cosmetics Global (Paris, France from April 16 to April 18, 2024) for its patented Bio-pulsed Exosomes (Extracellular Vesicles) raw materials and related derivatives products. In-cosmetics Global is a leading international cosmetics tradeshow annually for worldwide network of personal care ingredients and cosmetic ingredient; the exhibition displays the best achievements in the global cosmetics industry and can be called the “Oscars Global event for the cosmetics industry”. For personal care & cosmetics ingredients exhibitors, suppliers & manufactures included outstanding top cosmetic raw material suppliers such as BASF, Croda, Ashland, Solvay, Evonik, etc., exhibiting their new generation of innovative cosmetic raw materials. Leading international cosmetics brands and manufacturers such as L’Oreal, Unilever, Procter & Gamble, Estee Lauder, Kenvue, LVMH, etc. they are looking for excellent innovative cosmetic raw materials that comply with international regulations as a new generation of cutting-edge cosmetics for development and application.

ExoGiov® is a Biochemical-pulsed exosome; developed by AM BIOTECH; specifically designed for facial beauty and hair health. It is a specific-pathogen-free (SPF) chicken embryonic mesenchymal cell-derived extracellular vesicles, which is complies with international standards and regulations acceptable worldwide (INCI: chicken embryonic mesenchymal cell-derived extracellular vesicles). The Bio-pulsed exosome with inducing activated function is a self-developed patented cosmetic ingredient in combined the key 4 pillars innovation of (Clinical breakthroughs, Product innovation, Ingredient innovation, Research and Biotechnology innovation); its excellent efficacy results surpass ordinary exosomes and common cosmetic ingredients. The results and efficacy data were also published in the international Journal of Molecular Science.

AM BIOTECH Biochemical-pulsed exosome was selected as one of the top five innovation cosmetics raw materials in the world at 2024 in-cosmetics Global by the Estée Lauder Company’s New Incubation Ventures (NIV) BRKTHRU VOICES Prize. Hence, it is not only AM BIOTECH has the honor with international affirmation in advance medical research & innovation; but also, the opportunity to expand the worldwide market internationally for ExoGiov® Biochemical Pulsed Exosomes in important professional facial beauty & haircare channels.

Dr. Richard Hsieh, Chairman and Founder of AM BIOTECH for his leading Biochemical Pulse Exosomes, he particularly emphasized that exosome manufacturers around the world are planning for globalization in the international market, and AM BIOTECH is no exception. Although South Korea, Japan and even Taiwan have opened to use human Cell-derived exosomes for cosmetic raw materials, but in order to be able to integrate with the international market, so that the products can go out of Taiwan and take a global view, they must comply with the cosmetics regulations of most mainstream international markets. It can be seen that there is no company that used human-derived exosomes has joined the 2024 In-cosmetics Global exhibition.

AM BIOTECH ExoGiov® exosome complies with international standards and regulations acceptable worldwide, which is specific-pathogen-free (SPF) chicken embryonic mesenchymal cell-derived extracellular vesicles, and the others ordinary exosomes are mostly plant-derived exosomes. Furthermore, ExoGiov® is the world’s only Bio-pulsed exosome raw material for inducing facial beauty and hair growth functions.

This innovation breakthrough is the core of ExoGiov® patented biochemical pulsed functional-inducing-exosome technology, it can precisely regulate the expression of miRNA genes to make it better than ordinary Exosomes and general cosmetic raw materials. The effectiveness of ExoGiov® are dozens of times more effective in facial beauty and hair health, such as collagen type I and type III, elastin, skin fibroblast proliferation, melanin degradation, and hair follicle cell proliferation. It has produced excellent results in all aspects.

AM BIOTECH’s latest research on promoting hair follicle cell proliferation, it was further found that Minoxidil (the active ingredient of Rogaine) has an 87% hair follicle cell proliferation rate and a 20% hair follicle cell proliferation rate with generally non-functional inducing exosomes. The hair follicle cell proliferation rate of AM BIOTECH BIO-Pulsed Exosomes is 113%, and its efficacy is very outstanding.

AM BIOTECH Bio-Pulsed Exosomes has innovation break through on this cosmetic application, the storage and the regulation limitation. ExoGiov® patented biochemical pulsed functional-inducing-exosome has the uniqueness of 99.99% high-purity exosomes and can be stored at room temperature, they comply with the international cosmetic regulations and banning exosomes derived from human cells in most countries. The exosomes are the uniqueness of 99.99% high-purity exosomes and can be stored at room temperature.Most of the exosomes currently on the market are need to be keep in frozen temperature or refrigerated in low temperature to ensure bioactivity, their application in the development and application of cosmetic products is very limited.

AM BIOTECH entered into the top five finalist’s breakthrough innovation cosmetics raw materials in the world for the Estée Lauder (NIV) BRKTHRU VOICES Prize at 2024 In-cosmetics Global. ExoGiov® BIO-Pulsed Exosomes demonstrates its development advantages in the international market, the Estée Lauder (NIV) Executive Officer Mr. Ryan J. Piela and his expert team also saw these advantages and characteristics of AM BIOTECH Biochemical-Pulsed Exosomes. This professional recognition from Estée Lauder company has also prompted many other international cosmetics brands and cosmetics ingredients distributor agents from various international countries to inquire about AM BIOTECH the exosomes business cooperation.

AM BIOTECH becomes the first Taiwan’s exosomes to enter the international market, the Glory of Taiwan.  AM BIOTECH has officially launched the ExoGiov® Bio-pulsed exosomes in use and application in the cosmetics ingredient and LA EXO® related skincare & haircare products.

Read Moreread more

Join Us at 2026 New York Society of Cosmetic Chemists

2026-05-08

Join Us at Cosmopack Asia 2025

2025-10-23

AM Biotech is honored to participate in Cosmopack Asia 2025, where we will present our

Join Us at the 2025 Autumn International Beauty & Cosmetics Show

2025-09-15

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With

Reference: Journal of Controlled Release〈BDNF-enriched small extracellular vesicles protect against noise-induced hearing loss in mice〉

Hearing loss is a prevalent and often underestimated global health issue affecting people of all ages. According to the World Health Organization’s “World Report on Hearing,” as of 2021, about one-fifth of the global population suffers from hearing impairment, a figure projected to rise to one-quarter by 2050.

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by nerves. Damage to these cochlear hair cells and nerves can lead to permanent hearing impairment.

The cochlea contains a structure similar to the blood-brain barrier, known as the blood-labyrinth barrier (BLB), which prevents many large molecular drugs from treating the hair cells and cochlear nerves. However, advancements in nanotechnology within biomedical research have identified a type of nanoparticle—exosomes—that can potentially cross this barrier to treat hair cells and nerves.

The focus of this recent study is on exosomes wrapped with Brain-Derived Neurotrophic Factor (BDNF), which are used to aid in the repair of cochlear hair cells and nerves:

Researchers first isolated exosomes and encapsulated them with BDNF (referred to as BDNF-sEV). They then conducted animal experiments where mice were given BDNF-sEV through intravenous injections. The mice were subsequently exposed to a noisy environment to induce hearing loss, followed by another injection of BDNF-sEV.

After 14 days, the condition of the cochlear hair cells and nerves in the mice was assessed. The results showed that the mice’s hair cells and nerves were severely damaged after noise exposure. However, post-treatment with BDNF-sEV, the cochlear hair cells and nerves showed significant repair.

This study demonstrates the potential of exosomes in preventing and repairing hearing damage. Recent research also indicates that exosomes have performed well in nerve repair, suggesting that they could provide new hope for future clinical applications.

Under noise exposure, the condition of exosomes in preventing and repairing damaged hair cells. (Edit by AM Biotech study team)

Under noise exposure, the condition of exosomes in preventing and repairing damage to cochlear nerves. (Edit by AM Biotech study team)

For more articlesread more

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

2024-05-24

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves

2024-04-24

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing

2024-03-27

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

Stem Cell Exosomes with Specific miRNAs: A New Frontier in Treating Male Pattern Baldness

2024-03-13

As the exploration of exosomes in clinical settings progresses, there's growing anticipation for their integration with existing treatments like Minoxidil and Finasteride. This innovative approach could herald a more comprehensive and effective solution for tackling male pattern baldness, promising a new era of hair loss

Exosomes Aid in Repairing Skin Aging Caused by UV Radiation

2024-02-02

Overexposure to UV rays stimulates the production of free radicals, leading to wrinkles, spots, and dullness. Therefore, it is essential to use sunscreen and engage in proper skincare to prevent and repair the signs of skin aging.

Anti-Aging Study: Exosomes Regulate Aging Skeletal Muscle

2024-01-05

Extracellular vesicles, including exosomes and microvesicles, are an important medium for intercellular communication, with nearly all cells secreting these vesicles. The research team compared aging muscle stem cells cultured with young serum to those with young serum depleted of extracellular vesicles, observing the impact of

Can Exosomes Also Treat Dry Eye Syndrome?!

2023-12-19

Biologically and medically speaking, immune cells activated after transplantation continuously attack hematopoietic tissues and ocular epithelial tissues, including the cornea, conjunctiva, and lacrimal glands, causing widespread inflammation.

We are excited to announce our participation at 𝐈𝐧-𝐂𝐨𝐬𝐦𝐞𝐭𝐢𝐜𝐬 𝟐𝟎𝟐𝟒 in Paris, April 16-18. This year, we will unveil a groundbreaking development in skincare science: the “Bio-Pulsed” Exosome. Leveraging our patented technology and backed by robust scientific research, this innovative ingredient significantly enhances specific effects, surpassing traditional cosmetics by orders of magnitude.

To offer a glimpse into the wonders we’re bringing to the event, our pioneering product is capable of boosting relative mRNA expression by an astonishing 𝟐𝟓𝟎%, specifically targeting collagen type I. And that’s just a taste of the myriad benefits awaiting you, all achieved harmoniously without any side effects.

We warmly invite you to join us 𝗯𝗼𝗼𝘁𝗵 𝟭𝗩𝟭𝟳𝟰 for a heartfelt exchange about the science, beauty, and the inspiration behind our groundbreaking technology. Let’s share stories, insights, and dreams about the future of skincare. Looking forward to seeing you soon!

in-cosmetics Global 2024

For more articlesread more

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

2024-05-24

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves

2024-04-24

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing

2024-03-27

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

Stem Cell Exosomes with Specific miRNAs: A New Frontier in Treating Male Pattern Baldness

2024-03-13

As the exploration of exosomes in clinical settings progresses, there's growing anticipation for their integration with existing treatments like Minoxidil and Finasteride. This innovative approach could herald a more comprehensive and effective solution for tackling male pattern baldness, promising a new era of hair loss

Exosomes Aid in Repairing Skin Aging Caused by UV Radiation

2024-02-02

Overexposure to UV rays stimulates the production of free radicals, leading to wrinkles, spots, and dullness. Therefore, it is essential to use sunscreen and engage in proper skincare to prevent and repair the signs of skin aging.

Anti-Aging Study: Exosomes Regulate Aging Skeletal Muscle

2024-01-05

Extracellular vesicles, including exosomes and microvesicles, are an important medium for intercellular communication, with nearly all cells secreting these vesicles. The research team compared aging muscle stem cells cultured with young serum to those with young serum depleted of extracellular vesicles, observing the impact of

Can Exosomes Also Treat Dry Eye Syndrome?!

2023-12-19

Biologically and medically speaking, immune cells activated after transplantation continuously attack hematopoietic tissues and ocular epithelial tissues, including the cornea, conjunctiva, and lacrimal glands, causing widespread inflammation.